aloe emodin has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Li, S; Ma, Y; Wu, X; Zhang, H | 1 |
| Chen, W; Li, S; Ma, Y | 1 |
2 other study(ies) available for aloe emodin and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
Topics: Animals; Drugs, Chinese Herbal; Emodin; Lipids; Mice; Molecular Docking Simulation; Network Pharmacology; NF-kappa B; Non-alcoholic Fatty Liver Disease; Tumor Necrosis Factor-alpha | 2023 |
Active ingredients of Erhuang Quzhi Granules for treating non-alcoholic fatty liver disease based on the NF-κB/NLRP3 pathway.
Topics: Animals; Curcumin; Emodin; Inflammasomes; Molecular Docking Simulation; Molecular Structure; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease | 2023 |